Cargando…
Biomarkers of multiple sclerosis: current findings
Multiple sclerosis (MS) is an autoimmune disease affecting the brain and spinal cord that is associated with chronic inflammation leading to demyelination and neurodegeneration. With the recent increase in the number of available therapies for MS, optimal treatment will be based on a personalized ap...
Autores principales: | Harris, Violaine K, Tuddenham, John F, Sadiq, Saud A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053099/ https://www.ncbi.nlm.nih.gov/pubmed/30050375 http://dx.doi.org/10.2147/DNND.S98936 |
Ejemplares similares
-
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status
por: Harris, Violaine K., et al.
Publicado: (2014) -
Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response
por: Harris, Violaine K., et al.
Publicado: (2017) -
Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study
por: Harris, Violaine K., et al.
Publicado: (2020) -
Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis
por: Harris, Violaine K., et al.
Publicado: (2023) -
CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis
por: Mir, Fozia, et al.
Publicado: (2014)